Plasma atrial natriuretic peptide response to direct current cardioversion of atrial fibrillation in patients with mitral stenosis  by Fujiwara, Hitoshi et al.
JACC Vol . 22 . No. 2
August 1993 : 575-90
Pl
	
Atrial Natriuretic Peptide Response to Direct Current
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Objectives. The purpose of this study was to evaluate the effect
of direct current cardioversion therapy on the plasma concentra-
tion of strial natriuretic peptide and to determine the main factors
that influence the change in plasma atrial natriuretic peptide levels
in patients with atrlai librilhdlen .
Background. In atrial arrythmias, whether the fast atrial rate
itself or the associated elevation of atria) pressure, or both,
contributes to the Increase in atria) natriuretic peptide is a subject
of debate.
Methods. In 15 patients with mild mitral stenosis, plasma atria)
natriurelic peptide levels were measured and transmitral flow
pattern was obtained by continuous wave Doppler echocardiogra-
phy immediately before cardioversion and at 5 min, 4 h, 24 b and
5 days after direct current cardioversion . Mean mitral pressure
gradient and atrial filling fraction were calculated on the basis of
ransmitral flow .
Results . In three patients who did not have a successful return
to sinus rhythm, plasma atrial natriuretic peptide levels remained
elevated after cardioversion . In 12 patients who maintained sinus
Peptides with potent vasodilator and diuretic activities have
been purified from animal and human atrial extracts (1-8) .
Atrial natriuretic peptide is released from atrial myocytes
not only in congestive heart failure, but also in atrial and
ventricular tachyarrythmias (9-12) . However, the mecha-
nism of atria) natriuretic peptide release from the atria still
remains controversial, particularly in the setting of cardiac
arrythmias. For example, in atrial arrythmias, whether the
fast atrial rate itself or the associated elevation of atrial
pressure, or both, contribute to the increase in atrial natri-
uretic peptide is a subject of debate (13,14) . It has been
observed that repetitive electrical stimulation of the isolated
left atrium released atrial natriuretic peptide in the bathing
solution, indicating that stimulation frequency was the mod-
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rhythm, plasma atria) natriuretic peptide levels were significantly
reduced from 79 ± 29 to 36 ± 11 pglnd 4 h after cardioversion to
sinus rhythm. However, the mural pressure gradient did not
change significantly during the observation period . There were
progressive increases in atrial filling fraction throughout the
observation period. From 4 h to 5 days after direct current
cardioversion, plasma atrial natriuretic peptide levels gradually
increased concomitantly with the recovery of atria) mechanical
function.
Conclusion . The reduction of plasma atria) natriuretic peptide
levels after direct current cardioversion might be due to recovery
from the high rate of atria) firing and not to an alteration in the
mitral pressure gradient . Direct current cardioversion itself does
not seem to influence atrial natriuretic peptide secretion . The
Increase in atrial natriuretic peptide levels from 4 h to 5 days after
cardioversion concomitantly with an increase in atrial filling
fraction may be due to recovery of atrial mechanical function .
(J Am Coll Cardiol 1993;22:575-80)
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ulator of atrial natriuzetic peptide release in this setting (13) .
We have consistently shown that in patients with mitral
stenosis, the plasma concentration of atria! uatriuretic pep-
tide depends on left atria) pressure, whether or not there is
atrial fibrillation (15,16) .
The purpose of the present study was to evaluate the
effect of cardioversion on the plasma concentration of atria)
natriuretic peptide and to determine the main factors influ-
encing the change in plasma atrial natriuretic peptide in
patients with atria) fibrillation after direct current cardiover-
sion to sinus rhythm .
Methods
Study patients. We studied 15 patients with atria) fibril-
lation and mild mitral stenosis . All patients were treated by
percutaneous transvenous mitral commissurotomy . Nine
had grade I/Vl and three had grade Il/V1 mitral regurgitation
after commissurotomy . All patients underwent elective di-
rect current cardioversion for atria] fibrillation . The mean
age of the 4 men and I I women was 50 years (range 40 to 66) .
The known duration of atrial fibrillation ranged from 3 to 240
months (mean 52) .
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percutaneaus transvenous mural commlssurotolny
. All
patients underwent this procedure as previously described
(17,18)
. Right and left heart pressures and mean mitral
pressure gradient were measured before and after commis-
surotomy . Left ventriculography was performed before and
after commissurotomy. The severity of mitral regurgitation
from left ventriculography was graded semiquantiiatively
Direct current cardloversion. All patients underwent di-
rect
current cardioversion 9 days after percutaneous trans-
venous mitral eommissurotomy
. Anticoagulant therapy was
started at least I week before cardioversion, with doses of
oral warfarin
sufficient
to maintain a prothrombin time of
30% to 40%. Moreover, to confirm the absence of left atrial
thrombus, all patients underwent transesophageal echocar-
diography within 48 h before cardioversion . There was no
evidence of significant left atrial thrombus in any patient .
Eleven of 13 patients had been receiving digoxin, which was
withheld before elective cardioversion. Treatment with dis-
opyramide (300 mg/day) was started a few days before
cardioversion in all patients . After induction of general
anesthesia with intravenous pentobarbital calcium, direct
current cardioversion was performed with initial 100-J
shocks. In the unsuccessful cases, we repeated the proce-
dure with added 50-J shocks . However, we terminated the
protocol in three patients after cardioversion with 200-J
shocks was unsuccessful. Twelve patients were continued
on maintenance doses of the medications they were taking
before cardioversion throughout the observation period .
Echocardlographic studies, Two-dimensional and contin-
uous wave Doppler echocardiographic examinations were
performed with a Toshiba 140A Doppler system with a 2 .5-
or 3.75-MHz phased array transducer . Patients were exam-
ined in the supine position after sedation immediately before
cardioversion and at 5 min . 4 h, 24 h and 5 days after
cardioversion . Left aerial dimension at end-systole was
measured in the parasternal long-axis view with use of the
leading edge technique from M-mode tracings (20,21) . Trans.
mitral Row profile was recorded by continuous wave Dopp-
ler echocardiography from the apical two-chamber view,
Hard copy recordings were made at paper speeds of
50 mints. Doppler signals were digitalized with use of a
microcomputer (NEC 9800) . The mean mitral pressure gra-
dient was obtained from the integral of the instantaneous
pressure gradient along the velocity profile . The atrial filling
fraction (i.e., the percent atrial contribution to total left
ventricular filling) was determined by extrapolating the early
diastolic descent of the mitral velocity profile to end-diastole
in order to separate the atrial component (22-24). Atria)
Aft fraction was calculated as the quotient of the atrial
component and the total left ventricular
filling
time-velocity
integral (Fig. 1). At the same time, systemic blood pressure
and heart rate were measured .
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Figure 1 . Transmitral flow velocity was recorded by continuous
wave Doppler echocardiography from the apical two-chamber view
(upper pl nel) . Atrial filling fraction (dark shaded area) was the
percent atrial contribution to total left ventricular filling and was
determined by extrapolating the early diastolic descent of the mitral
velocity profile to end-diastole in order to separate the atral
component. The atrial filling fraction was calculated as the quotient
of the atria) component and the total left ventricular filling time-
velocity integral (lower panel) .
Blood sampling and hormone assay. Blood samples were
drawn from a peripheral vein into the tube containing
ethylenediaminetetraacetic acid and aprotinin as reported
(25). Blood samples were obtained immediately before car-
dioversion and at 5 min, 4 h, 24 h and 5 days after
cardioversion. Plasma concentration of atrial natriuretic
peptide was determined by specific radioimmunoassay after
extraction with octadecylsilane cartridges as previously de-
scribed (26) .
Statistical analysis. Data are expressed as mean value ±
SD. Statistical significance of serial changes in the plasma
concentration of atria( natriuretic peptide, Doppler echocar-
diographic variables. left atrial dimension and hemodynamic
variables during the study period were assessed by multiple
comparison analysis (ANOVA, followed by the
Scheffd F
test) . The statistical significance of changes in hemodynamic
variables during percutaneous transvenous mitral commis-
surotomy was assessed by Student i tests . A probability
value < 0.05 was considered significant .
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'fable 1. Changes in Atria] Natriuretic Peptide and Other Hemodynamic Data
Results
Results of percutaneous transvenous mitral conm'issurot-
otttty . Mitral valve area evaluated by two-dimensional echo-
cardiography increased from 1 . I ± 0 .4 to 1 .9 ± 0.4 cm 2 after
percutaneous transvenous mitral commissurotomy in all 15
patients p < 0.01 . Mean transmitral pressure gradient
calculated by cardiac catheterization decreased from 9 .5 ± 3
to 4.1 ± 2.2 mm Hg p < 0 .01 . Mitral regurgitation increased
in nine patients . However, there were no patients with
severe mitral regurgitation >grade III/VI.
Direct current cardioversion . In 12 of 15 pants sinus
rhythm was restored immediately after direct current cardio-
version and maintained beyond 5 days . In three patients in
whom cardioversion was unsuccessful with 200-J shocks, no
further cardioversion was attempted .
Plasma atrial natriuretic peptide levels . In three patients
who did not have a successful return to sinus rhythm, plasma
concentration of atrial natriuretic peptide was 42 ± 8, 39
6 and 41 ± 10 pgimi immediately before cardioversion and at
Figure 2. Plots of changes in plasma atrial natriuretic peptide
immediately before prior cardioversion and at 5 min, 4 h . 24 h and
5 days after cardioversion to sinus rhythm, p < 0.05 before vs . 4 h,
before vs . 24 h, before vs . 5 days . 5 min vs . 4 h, 5 min vs . 5 days and
4 h vs . 5 days . Squares and dashed lines indicate mean values for the
group as a whole . Short bars indicate SD . Circles and lines indicate
values for individual patients .
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Statistical analysis by analysis of variance, followed
by the Schelffe F test . Atrial filling fraction
AFF
: p -
0.05
5 min vs . 224 h, 5 min vs . 5 days, 4 h vs . 24 h, 4 h vs, 5 days, 24 h vs
. 5 days . Atrial
natriuretic peptide ANP : p <
0.05 brfare cardioversion vs,
4 h, before cardioversion vs . 24 h . before cardioversion
vs . 5 days . 5 min vs . 4 h
. 5 min
-is . 5 days, 4 h vs . 5 days, Heart
rate HR : p < 0 .05 before cardioversion
vs . 4 h, before cardioversion vs
. 24 h, before
cardioversion vs. 5 days,
5 min vs . 24 h . Left atrial dimension LAD
: p = NS. Mean mitral pressure gradient
MPG :
p = NS . Systolic blood pressure
SBPh p = NS .
ANP Levels 104
Mitral PG 4.4
4OWtrn
Atrial filling 0
fraction i
5.6
13 .3
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5 min and 4 h after cardioversion, respectively . In 12 patients
who maintained sinus rhythm, plasma concentration of atrial
natriuretic peptide was 79 ± 29, 69 ± 27, 36 ± 11, 44 ± 13
and 55 ± 19 pglml immediately before cardioversion and at
5 min, 4 h, 24 h and 5 days after cardioversion to sinus
rhythm, respectively Table I, Fig . 2 . Plasma concentration
of atrial natriuretic peptide was significantly reduced from
79 ± 29 to 36 ± 11 pg/mi 4 h after cardioversion to sinus rhythm
p < 0.05 . From 4 h to 5 days after cardioversion, the plasma
concentration of atrial natriuretic peptide gradually increased
to 55 ± 19 pg ml p < 0.05 .
Serial changes of transmitral flow profile . Mean mitral
pressure gradient was 4 .7 ± 1 .5, 4.0 ± 1 .2, 4 .0 ± 1 .6, 4.0 ±
1 .5, 4.1 ± 1 .2 mm Hg immediately before cardioversion and
at 5 min, 4 a, 24 h and 5 days after cardioversion to sinus
rhythm, respectively . Mean mitral pressure gradient did not
change during study period . Atrial filling fraction in was
0, 1 .4 ± 3.1, 3.4 ± 4 .1 . 6.1 ± 4.2, 9.3 ± 3.9 immediately
before cardi .wersion and at 5 min, 4 h, 24 h and 5 days after
r
•
.
Figure 3. Example of serial changes in transmittal flow profile and
plasma concentration of atrial natriuretic peptide ANP . Plasmaa
concentration of atrial natriuretic peptide was significantly de-
creased from 104 to 43 pg/ml 4 h after cardioversion . Atrial natri-
uretic peptide then gradually increased to 90 pglml 5 days after
cardioversion . However, during this period, mean mitral pressure
gradient PG did not change significantly . An identifiable atrial
filling wave arrowheads was seen 4 h after cardioversion . Atrial
filling fraction was gradually increased from 4 .5 4 h after cardio-
version to 13 .3 5 days after cardioversion to sinus rhythm . Bar at
right represents velocity .
Prier 5 Minutes 4 Hours 24 Hours 5 Days
ANP pg1ml 79 ± 29 69 ± 27 36 :t 11 44 ± 13 55 ± 19
MPG 4mm Hg 4.7±1 .5 4 .0 ± 1 .2 4 .0 _1 .6 4 .0 ± 1 .5 4 .1 ± 1 .2
AFF 7r 0 1 .4 ± 3 .1 3 .4 ± 4 .1 6.1±4 .2 9 .3 -~ 3 .9
LAD mm 46 5 45 ± 4 46 ± 4 46 . 5 46 . 4
HR heatti"min 82 ± 22 72
r
8 67 t 6 63 ± 7 65 ± 12
SBP mm Hg 119 ± 11 123 ± 13 126 ± 13 119 ± 9 119 ± 12
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Figure 4. Plots of changes in mean mitr.t : pressure gradient upper
panel and atria filling fraction lower panel immediately before
prior cardioversion and at 5 min, 4 h, 24 h and 5 days after
cardioversion to sinus rhythm . p < 0 .05, atria filling fraction: 5 nun
vs. 24 h. 5 mitt vs. 5 days, 4 h vs . 24 h . 4 h vs . 5 days and 24 h vs .
5 days. Symbols as in Figure 2 .
cardioversion to sinus rhythm, respectively, identifiable
atria filling wave was seen in 3 of 12 patients on the
transmittal flow recording performed at 5 min after cardio-
version . At 4 h after cardioversion, an identifiable atria
filling wave was seen in 6 patients . Aerial filling fraction was
increased continuously over the observation period Table t,
Fig. 3 and 4 .
Left aerial dimension and hemodynamic changes. Left
atria] dimension did not change during study period . Mean
heart rate was 82 # 22, 72 ± 8, 67 ± 6, 63 ± 7, 65 ± 12
beatslmin immediately before cardioversion and at 5 min,
4 h, 24 h and 5 days after cardioversion to sinus rhythm,
respectively. Mean heart rate was significantly reduced 4 h
after cardioversion to sinus rhythm p < 0.05 . Systemic
systolic blood pressure did not change during study period
Table 1, Fig . 5 .
Changes in plasma atria natriuretic peptide and in home .
dynamic vtria s. The plasma concentration of atria natri-
uretic peptide was significantly reduced 4 h after direct
current caixhoversion to sinus rhythm
. Mean mitral pressure
gradient did not differ significantly between immediately
before cardioversion and 4 h after cardioversion . From 4 h to
5 days after cardioversion plasma concentration of atria
natriuretic peptide gradually increased
. Aerial filling fraction
gradually increased to 9 .3 t 3.9 5 days after cardioversion .
Left aerial dimension, heart rate and systolic blood pressure
did not change from 4 h to 5 days after cardioversion .
Discussion
Reduction of atria natriuretic peptide after cardioversion .
Recent studies 27-30 have demonstrated increased plasma
concentrations of atria natriuretic peptide in patients with
atria fibrillation . Roy et al . 29 reported that plasma atria
natriuretic peptide Ic .cls were high in patients with aerial
fibrillation and decreased I h after cardioversion to sinus
rhythm. The authors 29 suggested that high atria pressure
and chronic atria stretch contributed to the high plasma
atria natriuretic peptide concentration during atria fibrilla-
tion, although they did not measure atria pressure in this
setting. An increase in plasma atria natriuretic peptide
concentration in atria arrythmias may be attributed to an
associated elevation of atria pressure in these circum-
Figure 3 . Plots of changes in left atria dimension upper panel ,
mean heart rate middle panel and systemic systolic blood pressure
lower panel immediately before prior cardioversion and at 5 min,
4 h . 24 h and 5 days after cardirversion to sinus rhythm . p < 0.05,
heart rate: before vs . 4 h, before vs . 24 h, before vs. 5 days and 5 min
vs . 24 h . Symbols as in Figure 2, bpm = beats per minute .
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stances . Likewise, the decrease after cardioversion in atrial
natriuretic peptide concentration has been explained by the
decrease in atrial pressure resulting from restoration of sinus
rhythm. We 15 have already reported the rapid reduction of
plasma atrial natriuretic peptide concentration with a con-
comitant rapid decrease in left atrial pressure and indicated
that left atrial pressure was the most important factor
influencing atrial natriuretic peptide secretion in patients
with mitral stenosis. Dussaule et al . 31 also indicated that
there was an increase in atrial natriuretic peptide secretion,
depending on left atrial pressure, in patients with mitral
stenosis and sinus rhythm . In our present study, we mea-
sured mean mitral pressure gradient estimated by Doppler
echocardiography instead of evaluating left atrial pressure .
We showed that during exercise, the most important factor
influencing the secretion of atrial natriuretic peptide may be
the alteration of transmitral pressure gradient in patients
with mitral stenosis 16 .
In the present study, the plasma concentration of atrial
natriuretic peptide decreased significantly without changes
in mean mitral pressure gradient and left atrial dimension 4 h
after cardioversion. The reduction in atrial natriuretic pep-
tide does not seem to be due to the change in mean mitral
pressure gradient .
Effect of cardioversion itself on atrial natriuretic peptide
secretion. To ascertain if cardioversion itself might influence
plasma atrial natriuretic peptide levels, we studied three
patients who did not recover from atrial fibrillation . The
plasma concentration of atrial natriuretic peptide in those
three patients did not significantly change after cardiover-
sion. Therefore, direct current cardioversion itself does not
seem to influence atrial natriuretic peptide secretion .
Main factor influencing the reduction of atrial natriuretic
peptide. Dussaule et al . 31 showed that the atrial natri-
uretic peptide level was also high in patients with mitral
stenosis and atrial fibrillation but did not respond appropri-
ately to changes in left atrial pressure . They tried to estimate
the relation of left atrial dimension to plasma atrial natri-
uretic peptide release . Left atrial dimension tended to be
greater in patients with atrial fibrillation than in those with
sinus rhythm. They concluded that it was likely that high
plasma atrial nati iuretic peptide levels and the inappropriate
response of plasma atrial natriuretic peptide to the decrease
in left atrial pressure observed in patients with atrial fibril-
lation were due to several related factors such as a high rate
of atrial firing, abnormal stretch of the atrial wall and larger
atrial volume 31 . Microelectrode studies 32 have indi-
cated that cells in the fibrillating atrium may fire 500 times/
min. This very high rate could participate in the pathophys-
iologic effects we observed. The reduction of atrial
natriuretic peptide concentration after cardioversion to sinus
rhythm might be reflected by recovery from the high rate of
atrial firing . Although we did not assess atrial pressure
;
directly, our noninvasive data strongly suggested that a high
rate of firing alone could cause an elevation in plasma atrial
FUJIWARA ET AL
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natriuretic peptide without changes in mitral pressure gradi-
ent and atrial size in patients with mitral stenosis .
Increase in atrial natriuretic peptide after restoration of
sinus rhythm. Manning et al . 33 reported that the percent
atrial contribution to left ventricular filling did not return to
normal until 3 weeks after cardioversion in patients with
atrial fibrillation . The present study indicated that full recov-
ery of atrial mechanical function did not occur immediately
after successful direct current cardioversion of atrial fibril-
lation to sinus rhythm, but it increased from 4 h to 5 days
after cardioversion. Plasma concentrations of atrial natri-
uretic peptide gradually increased from 4 h to 5 days after
cardioversion . Other variables such as mean mitral pressure
gradient, left atrial dimension, heart rate and systolic blood
pressure Jid aot change from 4 h to 5 days . The increase in
atrial natriuretic peptide from 4 h to 5 days after cardiover-
sion was concomitant with the increase in atrial filling
fraction and might be due to changes in atrial mechanical
function. Thus, recovery of atrial mechanical function seems
to play a role in atrial natriuretic peptide secretion .
Limitations of the study . We could not assess left atrial
pressure because of practical limitations . Instead, we mea-
sured mean mitral pressure gradient obtained by Doppler
echocardiography because there was a close correlation
between this variable and left atrial pressure .
The improvement in atrial mechanical function might
appear to continue for up to several weeks after cardiover-
sion in most patients . In this study, we could not evaluate
the changes in atrial natriuretic peptide up to the time of full
recovery of atrial function . However, the improvement in
atrial mechanical function within I week may be larger than
that during the next several weeks . Thus, the relation
between the improvement in atrial mechanical function and
the changes in plasma atrial natriuretic peptide levels could
be sufficiently evaluated within I week .
Conclusion. Plasma atrial natriuretic peptide levels de-
creased after direct current cardioversion in patients with
mitral stenosis and atrial fibrillation . The reduction of atrial
natriuretic peptide was independent of mean mitral pressure
gradient and left atrial size . The reduction of atrial natri-
uretic peptide after direct current cardioversion may be due
to recovery from the high rate of atrial firing . In cases where
sinus rhythm was maintained, atrial mechanical function
recovered gradually from 5 min to 5 days after cardiover-
sion. The increase in atrial natriuretic peptide from 4 h to 5
days after cardiovcrsion may be due to recovery of atrial
mechanical function .
We thank Goro Kajiyatna, MD and Elina Yamada, MD for helpful
advice .
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